Integral Derivatives’s AB InBev BUD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$297K Buy
2,700
+700
+35% +$77.6K 0.01% 508
2017
Q4
$223K Sell
2,000
-300
-13% -$35.3K ﹤0.01% 954
2017
Q3
$274K Sell
2,300
-1,900
-45% -$222K 0.01% 925
2017
Q2
$464K Buy
4,200
+1,300
+45% +$149K 0.01% 723
2017
Q1
$318K Buy
2,900
+300
+12% +$32.3K 0.01% 889
2016
Q4
$274K Buy
+2,600
New +$291K 0.01% 909
2016
Q3
Sell
-4,200
Closed -$553K 1001
2016
Q2
$553K Sell
4,200
-9,000
-68% -$1.13M 0.01% 569
2016
Q1
$1.65M Buy
+13,200
New +$1.57M 0.05% 259
2014
Q1
Sell
-2,500
Closed -$266K 1318
2013
Q4
$266K Buy
+2,500
New +$255K ﹤0.01% 1258

Other funds holding BUD

Integral Derivatives's BUD Position: Q3 2017 in Review

Integral Derivatives sold out of AB InBev (BUD) in Q3 2017, closing a stake of 2,425 shares — an estimated $284K sold.

Integral Derivatives first reported a position in BUD in Q1 2015 and held it in 5 quarters. The position peaked at $527K in Q2 2016. 533 funds tracked by Wall St. Rank hold BUD as of Q3 2017.

  • Integral Derivatives reported no remaining AB InBev position as of Q3 2017 after selling out during the quarter.
  • Integral Derivatives sold 2,425 AB InBev shares in Q3 2017, an estimated $284K.
  • Integral Derivatives first reported a position in AB InBev in Q1 2015 and held it in 5 quarters.
  • Integral Derivatives's AB InBev position peaked at $527K in Q2 2016.
  • 533 funds tracked by Wall St. Rank held AB InBev as of Q3 2017.

Based on Integral Derivatives's 13F filing for Q3 2017, filed 14 Nov 2017.